KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Other Working Capital Changes: 2018-2025

Historic Other Working Capital Changes for Castle Biosciences (CSTL) over the last 6 years, with Sep 2025 value amounting to -$161,000.

  • Castle Biosciences' Other Working Capital Changes fell 107.63% to -$161,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year increase of 8.97%. This contributed to the annual value of -$1.3 million for FY2024, which is 251.29% down from last year.
  • Per Castle Biosciences' latest filing, its Other Working Capital Changes stood at -$161,000 for Q3 2025, which was down 112.09% from $1.3 million recorded in Q2 2025.
  • Over the past 5 years, Castle Biosciences' Other Working Capital Changes peaked at $3.4 million during Q1 2025, and registered a low of -$3.2 million during Q3 2021.
  • For the 3-year period, Castle Biosciences' Other Working Capital Changes averaged around $372,545, with its median value being $135,000 (2023).
  • Per our database at Business Quant, Castle Biosciences' Other Working Capital Changes crashed by 1,401.55% in 2021 and then spiked by 1,463.70% in 2024.
  • Over the past 5 years, Castle Biosciences' Other Working Capital Changes (Quarterly) stood at -$3.0 million in 2021, then surged by 78.46% to -$646,000 in 2022, then skyrocketed by 62.69% to -$241,000 in 2023, then plummeted by 1,131.54% to -$3.0 million in 2024, then slumped by 107.63% to -$161,000 in 2025.
  • Its last three reported values are -$161,000 in Q3 2025, $1.3 million for Q2 2025, and $3.4 million during Q1 2025.